United States - English - NLM (National Library of Medicine)

golden state medical supply, inc. - ropinirole hydrochloride (unii: d7zd41rzi9) (ropinirole - unii:030pyr8953) - ropinirole 0.25 mg - ropinirole tablets are indicated for the treatment of parkinson’s disease. ropinirole tablets are indicated for the treatment of moderate-to-severe primary restless legs syndrome (rls). ropinirole tablets are contraindicated in patients known to have a hypersensitivity/allergic reaction (including urticaria, angioedema, rash, pruritus) to ropinirole or to any of the excipients. there are no adequate data on the developmental risk associated with the use of ropinirole tablets in pregnant women. in animal studies, ropinirole had adverse effects on development when administered to pregnant rats at doses similar to (neurobehavioral impairment) or greater than (teratogenicity and embryolethality at > 36 times) the mrhd for parkinson’s disease. ropinirole doses associated with teratogenicity and embryolethality in pregnant rats were associated with maternal toxicity. in pregnant rabbits, ropinirole potentiated the teratogenic effects of l-dopa when these drugs were administered in combination [see

Canada - English - Health Canada

teva canada limited - ropinirole (ropinirole hydrochloride) - tablet - 0.25mg - ropinirole (ropinirole hydrochloride) 0.25mg - nonergot-derivative dopamine receptor agonists

Canada - English - Health Canada

teva canada limited - ropinirole (ropinirole hydrochloride) - tablet - 1mg - ropinirole (ropinirole hydrochloride) 1mg - nonergot-derivative dopamine receptor agonists

Canada - English - Health Canada

teva canada limited - ropinirole (ropinirole hydrochloride) - tablet - 2mg - ropinirole (ropinirole hydrochloride) 2mg - nonergot-derivative dopamine receptor agonists

Canada - English - Health Canada

teva canada limited - ropinirole (ropinirole hydrochloride) - tablet - 5mg - ropinirole (ropinirole hydrochloride) 5mg - nonergot-derivative dopamine receptor agonists

Canada - English - Health Canada

pharmascience inc - ropinirole (ropinirole hydrochloride) - tablet - 0.25mg - ropinirole (ropinirole hydrochloride) 0.25mg - nonergot-derivative dopamine receptor agonists

Canada - English - Health Canada

pharmascience inc - ropinirole (ropinirole hydrochloride) - tablet - 0.5mg - ropinirole (ropinirole hydrochloride) 0.5mg - nonergot-derivative dopamine receptor agonists

Canada - English - Health Canada

pharmascience inc - ropinirole (ropinirole hydrochloride) - tablet - 1mg - ropinirole (ropinirole hydrochloride) 1mg - nonergot-derivative dopamine receptor agonists

Canada - English - Health Canada

pharmascience inc - ropinirole (ropinirole hydrochloride) - tablet - 2mg - ropinirole (ropinirole hydrochloride) 2mg - nonergot-derivative dopamine receptor agonists

Canada - English - Health Canada

pharmascience inc - ropinirole (ropinirole hydrochloride) - tablet - 5.0mg - ropinirole (ropinirole hydrochloride) 5.0mg - nonergot-derivative dopamine receptor agonists